Check Out What Whales Are Doing With PFE
Portfolio Pulse from Benzinga Insights
A significant bullish stance has been taken on Pfizer (NYSE:PFE) by a large investor, as observed in the publicly available options history. The overall sentiment of these big-money traders is split between 56% bullish and 43% bearish. The whales have been targeting a price range from $22.5 to $43.0 for Pfizer over the last 3 months. Currently, PFE's price is down -1.95% at $35.75. Cantor Fitzgerald and Credit Suisse have downgraded their actions on Pfizer with price targets of $75 and $40 respectively.

July 06, 2023 | 7:17 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
A large investor has taken a bullish stance on Pfizer, with big-money traders sentiment split between 56% bullish and 43% bearish. Pfizer's price is currently down -1.95% at $35.75.
The news of a large investor taking a bullish stance on Pfizer indicates a potential positive sentiment towards the stock. However, the overall sentiment of big-money traders is split, and the current price of Pfizer is down, indicating a mixed impact on the stock. The downgrades by Cantor Fitzgerald and Credit Suisse also add uncertainty to the stock's short-term performance.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100